Vertex Pharmaceuticals (VRTX) Current Taxes (2011 - 2014)

Vertex Pharmaceuticals' quarterly Current Taxes came in at $14.2 million in Q4 2014, up 1886.85% quarter-over-quarter from $715000.0 in Q4 2012.

Vertex Pharmaceuticals has reported Current Taxes for 3 years, with the latest figure at $14.2 million in Q4 2014.

For the quarter ending Q4 2014, Current Taxes changed N/A year-over-year to $14.2 million; the trailing twelve-month figure through Dec 2014 stood at $14.2 million (changed N/A YoY), and the FY2014 full-year result was $14.2 million, changed N/A from the prior year.
Current Taxes for Q4 2014 stood at $14.2 million, up from $715000.0 in the prior quarter.
The five-year high for Current Taxes was $14.2 million in Q4 2014, with the low at $201000.0 in Q1 2012.
Average Current Taxes over 3 years is $5.9 million, with a median of $3.9 million recorded in 2012.
Peak annual rise in Current Taxes reached 60.32% in 2012, while the deepest fall reached 94.08% in 2012.
Tracing VRTX's Current Taxes over 3 years: stood at $12.1 million in 2011, then tumbled by 94.08% to $715000.0 in 2012, then surged by 1886.85% to $14.2 million in 2014.
The last three Current Taxes figures came in at $14.2 million (Q4 2014), $715000.0 (Q4 2012), and $3.9 million (Q3 2012), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	10,460.56
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	19.20 Mn
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Revolution Medicines	32.39 Bn	32.39 Bn	-	-

Download Data 🔒